PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsRubicon Research
Rubicon Research
Rubicon Research is an IP led, specialty pharmaceutical company located in Mumbai, India. Its formulation development is across multiple dosage forms, oral solids, oral liquids, nasal, ophthalmic, topical, injectable, fixed dose combinations, and drug device combinations. In 2019 the company received USD 100 million in growth capital investment from General Atlantic, a growth equity firm.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AcetazolamideAcetazolamide2021-08-19
AcyclovirAcyclovir2022-08-182027-2030
AmantadineAmantadine2020-05-212025-2038
AmiodaroneAmiodarone2008-11-062029
AripiprazoleAripiprazole2022-10-272023-2034
BaclofenBaclofen2017-11-282037-2041
BisoprololBisoprolol2000-11-16
BuprenorphineBuprenorphine2015-06-102024-2038
BuspironeBuspirone2002-04-05
Carbidopa levodopaCarbidopa, Levodopa2022-09-212023-2039
CarvedilolCarvedilol2007-09-052025
CiprofloxacinCiprofloxacin2004-06-092025-2038
1
2
3
4
5
>
Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use